Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angray S Kang

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Proteome Science|June 21, 2005
Cognate peptide-receptor ligand mapping by directed phage displayThomas Stratmann, Angray S Kang
Human Antibodies|June 21, 2021
Immunogenicity of biologics used in the treatment of moderate to severe psoriasisVisha Patel, Alex Efimov, David Baker, et al.
Experimental Parasitology|March 9, 2010
Trypanosoma cruzi: synergistic cytotoxicity of multiple amphipathic anti-microbial peptides to T. cruzi and potential bacterial hostsAnnabeth Fieck, Ivy Hurwitz, Angray S Kang, et al.
Human Antibodies|December 16, 2004
IgG(4) Pf NPNA-1 a human anti-Plasmodium falciparum sporozoite monoclonal antibody cloned from a protected individual inhibits parasite invasion of hepatocytesJonathan A Chappel, Michael R Hollingdale, Angray S Kang
Human Antibodies|June 21, 2021
Immunogenicity of biologics used in the treatment of inflammatory bowel diseaseMariam Bqain, Alex Efimov, David Baker, et al.
Multiple Sclerosis and Related Disorders|January 5, 2024
Neutropenia following immune-depletion, notably CD20 targeting, therapies in multiple sclerosisDavid Baker, Angray S Kang, Gavin Giovannoni, et al.
Journal of Immunological Methods|November 9, 2010
Module based antibody engineering: a novel synthetic REDantibodyAnatoliy Markiv, Bernard Anani, Ravi V Durvasula, et al.
Signal Transduction and Targeted Therapy|July 4, 2020
Mapping the T cell response to COVID-19Junwei Li, Junhua Wang, Angray S Kang, et al.
Biochemistry|March 30, 2023
Exploring the "N-Terminal Anchor" Binding Interface of the T3SS Chaperone-Translocator Complexes from <i>P. aeruginosa</i>Charlotte L Frankling, Angray S Kang, Ewan R G Main
Multiple Sclerosis and Related Disorders|May 29, 2020
The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemicDavid Baker, Sandra Amor, Angray S Kang, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Proteome Science|June 21, 2005
Cognate peptide-receptor ligand mapping by directed phage displayThomas Stratmann, Angray S Kang
Human Antibodies|June 21, 2021
Immunogenicity of biologics used in the treatment of moderate to severe psoriasisVisha Patel, Alex Efimov, David Baker, et al.
Experimental Parasitology|March 9, 2010
Trypanosoma cruzi: synergistic cytotoxicity of multiple amphipathic anti-microbial peptides to T. cruzi and potential bacterial hostsAnnabeth Fieck, Ivy Hurwitz, Angray S Kang, et al.
Human Antibodies|December 16, 2004
IgG(4) Pf NPNA-1 a human anti-Plasmodium falciparum sporozoite monoclonal antibody cloned from a protected individual inhibits parasite invasion of hepatocytesJonathan A Chappel, Michael R Hollingdale, Angray S Kang
Human Antibodies|June 21, 2021
Immunogenicity of biologics used in the treatment of inflammatory bowel diseaseMariam Bqain, Alex Efimov, David Baker, et al.
Multiple Sclerosis and Related Disorders|January 5, 2024
Neutropenia following immune-depletion, notably CD20 targeting, therapies in multiple sclerosisDavid Baker, Angray S Kang, Gavin Giovannoni, et al.
Journal of Immunological Methods|November 9, 2010
Module based antibody engineering: a novel synthetic REDantibodyAnatoliy Markiv, Bernard Anani, Ravi V Durvasula, et al.
Signal Transduction and Targeted Therapy|July 4, 2020
Mapping the T cell response to COVID-19Junwei Li, Junhua Wang, Angray S Kang, et al.
Biochemistry|March 30, 2023
Exploring the "N-Terminal Anchor" Binding Interface of the T3SS Chaperone-Translocator Complexes from <i>P. aeruginosa</i>Charlotte L Frankling, Angray S Kang, Ewan R G Main
Multiple Sclerosis and Related Disorders|May 29, 2020
The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemicDavid Baker, Sandra Amor, Angray S Kang, et al.
Pageof 4